| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1 | 14 | 365 | 168 | 50 | - | - | 598 |
| - | - | - | - | - | 84 | 106 | 2 | - | - | 192 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 598 | 100.0% | -1.64 | 192 | 100.0% |
| upstream partner | # | NT | conns Cm_unclear | % In | CV |
|---|---|---|---|---|---|
| Dm2 (R) | 31 | ACh | 136 | 22.9% | 0.8 |
| Tm5c (R) | 11 | Glu | 52 | 8.8% | 0.8 |
| MeVPMe6 (L) | 1 | Glu | 40 | 6.7% | 0.0 |
| MeVP7 (R) | 5 | ACh | 28 | 4.7% | 0.8 |
| Cm10 (R) | 8 | GABA | 28 | 4.7% | 0.8 |
| Cm9 (R) | 6 | Glu | 27 | 4.5% | 0.8 |
| Dm8a (R) | 9 | Glu | 27 | 4.5% | 0.8 |
| TmY4 (R) | 5 | ACh | 18 | 3.0% | 0.5 |
| Mi10 (R) | 7 | ACh | 18 | 3.0% | 0.7 |
| LT58 (R) | 1 | Glu | 16 | 2.7% | 0.0 |
| R7y | 2 | HA | 15 | 2.5% | 0.1 |
| Tm20 (R) | 6 | ACh | 15 | 2.5% | 0.8 |
| MeTu1 (R) | 3 | ACh | 13 | 2.2% | 0.2 |
| Tm34 (R) | 2 | Glu | 10 | 1.7% | 0.6 |
| Cm30 (R) | 2 | GABA | 10 | 1.7% | 0.4 |
| Cm31a (R) | 2 | GABA | 10 | 1.7% | 0.0 |
| L5 (R) | 7 | ACh | 10 | 1.7% | 0.3 |
| Dm9 (R) | 3 | Glu | 9 | 1.5% | 0.5 |
| Mi15 (R) | 4 | ACh | 8 | 1.3% | 0.4 |
| Cm3 (R) | 5 | GABA | 7 | 1.2% | 0.3 |
| MeVP40 (R) | 1 | ACh | 5 | 0.8% | 0.0 |
| OLVC2 (L) | 1 | GABA | 5 | 0.8% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 5 | 0.8% | 0.0 |
| Cm5 (R) | 3 | GABA | 5 | 0.8% | 0.6 |
| MeVP6 (R) | 1 | Glu | 4 | 0.7% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| Tm29 (R) | 1 | Glu | 3 | 0.5% | 0.0 |
| TmY21 (R) | 1 | ACh | 3 | 0.5% | 0.0 |
| MeVP42 (R) | 1 | ACh | 3 | 0.5% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| TmY10 (R) | 2 | ACh | 3 | 0.5% | 0.3 |
| Cm7 (R) | 2 | Glu | 3 | 0.5% | 0.3 |
| OLVC4 (L) | 1 | unc | 2 | 0.3% | 0.0 |
| R7_unclear | 1 | HA | 2 | 0.3% | 0.0 |
| Dm11 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| Dm12 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| Cm17 (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| Cm23 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| MeVPLo2 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| MeVC10 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| Tm40 (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| TmY5a (R) | 2 | Glu | 2 | 0.3% | 0.0 |
| MeLo1 (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| Cm11c (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVC9 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Mi9 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm1 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm5a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm39 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| T2a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeLo4 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm6 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeLo3a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm30 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeTu4d (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm5Y (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm31 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm19 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm26 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP6_unclear (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm11d (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeLo11 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm21 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Pm8 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Mi18 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm28 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP21 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP33 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| aMe12 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| aMe17b (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| LT88 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm31b (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns Cm_unclear | % Out | CV |
|---|---|---|---|---|---|
| Cm3 (R) | 17 | GABA | 116 | 14.0% | 0.6 |
| Cm6 (R) | 15 | GABA | 103 | 12.4% | 0.5 |
| Tm31 (R) | 6 | GABA | 40 | 4.8% | 0.7 |
| Tm37 (R) | 13 | Glu | 39 | 4.7% | 0.8 |
| MeVP7 (R) | 7 | ACh | 38 | 4.6% | 0.6 |
| Cm8 (R) | 5 | GABA | 30 | 3.6% | 0.9 |
| Cm26 (R) | 5 | Glu | 29 | 3.5% | 0.7 |
| Cm1 (R) | 12 | ACh | 29 | 3.5% | 0.5 |
| Tm5c (R) | 11 | Glu | 27 | 3.3% | 0.9 |
| Dm2 (R) | 17 | ACh | 26 | 3.1% | 0.5 |
| Tm29 (R) | 6 | Glu | 24 | 2.9% | 0.7 |
| Cm23 (R) | 7 | Glu | 22 | 2.7% | 0.5 |
| Cm9 (R) | 9 | Glu | 22 | 2.7% | 0.5 |
| MeVP21 (R) | 2 | ACh | 17 | 2.0% | 0.5 |
| Cm7 (R) | 6 | Glu | 14 | 1.7% | 0.7 |
| Cm5 (R) | 8 | GABA | 14 | 1.7% | 0.9 |
| MeVP6 (R) | 2 | Glu | 13 | 1.6% | 0.8 |
| Tm30 (R) | 5 | GABA | 13 | 1.6% | 0.9 |
| Cm12 (R) | 7 | GABA | 13 | 1.6% | 0.4 |
| MeVP40 (R) | 1 | ACh | 12 | 1.4% | 0.0 |
| MeVP42 (R) | 1 | ACh | 12 | 1.4% | 0.0 |
| Cm33 (R) | 1 | GABA | 12 | 1.4% | 0.0 |
| MeLo3a (R) | 2 | ACh | 11 | 1.3% | 0.8 |
| MeLo4 (R) | 5 | ACh | 10 | 1.2% | 1.0 |
| aMe4 (R) | 3 | ACh | 9 | 1.1% | 0.5 |
| MeVPMe9 (R) | 2 | Glu | 8 | 1.0% | 0.2 |
| Cm17 (R) | 3 | GABA | 8 | 1.0% | 0.2 |
| TmY18 (R) | 3 | ACh | 7 | 0.8% | 0.2 |
| aMe5 (R) | 4 | ACh | 7 | 0.8% | 0.2 |
| MeVP6_unclear (R) | 1 | Glu | 6 | 0.7% | 0.0 |
| Cm21 (R) | 2 | GABA | 6 | 0.7% | 0.3 |
| Tm35 (R) | 1 | Glu | 5 | 0.6% | 0.0 |
| Cm11d (R) | 4 | ACh | 5 | 0.6% | 0.3 |
| MeVPMe7 (L) | 1 | Glu | 4 | 0.5% | 0.0 |
| MeVP43 (R) | 1 | ACh | 4 | 0.5% | 0.0 |
| aMe2 (R) | 2 | Glu | 4 | 0.5% | 0.5 |
| aMe17a (R) | 1 | unc | 3 | 0.4% | 0.0 |
| MeTu3c (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| Cm25 (R) | 1 | Glu | 3 | 0.4% | 0.0 |
| aMe3 (R) | 1 | Glu | 3 | 0.4% | 0.0 |
| MeVP25 (R) | 1 | ACh | 3 | 0.4% | 0.0 |
| MeVP56 (R) | 1 | Glu | 3 | 0.4% | 0.0 |
| aMe10 (R) | 2 | ACh | 3 | 0.4% | 0.3 |
| Cm30 (R) | 2 | GABA | 3 | 0.4% | 0.3 |
| MeTu4d (R) | 3 | ACh | 3 | 0.4% | 0.0 |
| MeVP1 (R) | 3 | ACh | 3 | 0.4% | 0.0 |
| Tm36 (R) | 3 | ACh | 3 | 0.4% | 0.0 |
| Cm4 (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| TmY4 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeTu1 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeLo7 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| Cm29 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| Cm35 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| Tm39 (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| MeTu4f (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| OLVC4 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| C2 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Dm8a (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi9 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi4 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| TmY5a (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP10 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm15 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm13 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Lawf2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm14 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Dm4 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm32 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPMe6 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LT58 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| l-LNv (R) | 1 | unc | 1 | 0.1% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 1 | 0.1% | 0.0 |